262 related articles for article (PubMed ID: 23954944)
1. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers.
Anizan S; Milman G; Desrosiers N; Barnes AJ; Gorelick DA; Huestis MA
Anal Bioanal Chem; 2013 Oct; 405(26):8451-61. PubMed ID: 23954944
[TBL] [Abstract][Full Text] [Related]
2. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid disposition in oral fluid after controlled smoked cannabis.
Lee D; Schwope DM; Milman G; Barnes AJ; Gorelick DA; Huestis MA
Clin Chem; 2012 Apr; 58(4):748-56. PubMed ID: 22273566
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers.
Newmeyer MN; Desrosiers NA; Lee D; Mendu DR; Barnes AJ; Gorelick DA; Huestis MA
Drug Test Anal; 2014 Oct; 6(10):1002-10. PubMed ID: 24652685
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.
Swortwood MJ; Newmeyer MN; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
Drug Test Anal; 2017 Jun; 9(6):905-915. PubMed ID: 27647820
[TBL] [Abstract][Full Text] [Related]
6. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
Lee D; Karschner EL; Milman G; Barnes AJ; Goodwin RS; Huestis MA
Drug Alcohol Depend; 2013 Jun; 130(1-3):68-76. PubMed ID: 23146820
[TBL] [Abstract][Full Text] [Related]
7. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
Desrosiers NA; Lee D; Concheiro-Guisan M; Scheidweiler KB; Gorelick DA; Huestis MA
Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
[TBL] [Abstract][Full Text] [Related]
8. Impact of oral fluid collection device on cannabinoid stability following smoked cannabis.
Anizan S; Bergamaschi MM; Barnes AJ; Milman G; Desrosiers N; Lee D; Gorelick DA; Huestis MA
Drug Test Anal; 2015 Feb; 7(2):114-20. PubMed ID: 24995604
[TBL] [Abstract][Full Text] [Related]
9. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking.
Lee D; Vandrey R; Mendu DR; Murray JA; Barnes AJ; Huestis MA
Drug Test Anal; 2015 Jun; 7(6):494-501. PubMed ID: 25220020
[TBL] [Abstract][Full Text] [Related]
10. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
Huestis MA; Sempio C; Newmeyer MN; Andersson M; Barnes AJ; Abulseoud OA; Blount BC; Schroeder J; Smith ML
J Anal Toxicol; 2020 Oct; 44(7):651-660. PubMed ID: 32369162
[TBL] [Abstract][Full Text] [Related]
11. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
Newmeyer MN; Swortwood MJ; Barnes AJ; Abulseoud OA; Scheidweiler KB; Huestis MA
Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices.
Desrosiers NA; Milman G; Mendu DR; Lee D; Barnes AJ; Gorelick DA; Huestis MA
Anal Bioanal Chem; 2014 Jul; 406(17):4117-28. PubMed ID: 24828976
[TBL] [Abstract][Full Text] [Related]
13. Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge.
Lee D; Vandrey R; Mendu DR; Anizan S; Milman G; Murray JA; Barnes AJ; Huestis MA
Clin Chem; 2013 Dec; 59(12):1770-9. PubMed ID: 23938457
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.
Milman G; Schwope DM; Gorelick DA; Huestis MA
Clin Chim Acta; 2012 Apr; 413(7-8):765-70. PubMed ID: 22285315
[TBL] [Abstract][Full Text] [Related]
15. On-site test for cannabinoids in oral fluid.
Desrosiers NA; Lee D; Schwope DM; Milman G; Barnes AJ; Gorelick DA; Huestis MA
Clin Chem; 2012 Oct; 58(10):1418-25. PubMed ID: 22912396
[TBL] [Abstract][Full Text] [Related]
16. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis.
Desrosiers NA; Himes SK; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
Clin Chem; 2014 Apr; 60(4):631-43. PubMed ID: 24563491
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
Fabritius M; Chtioui H; Battistella G; Annoni JM; Dao K; Favrat B; Fornari E; Lauer E; Maeder P; Giroud C
Anal Bioanal Chem; 2013 Dec; 405(30):9791-803. PubMed ID: 24202191
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids in exhaled breath following controlled administration of smoked cannabis.
Himes SK; Scheidweiler KB; Beck O; Gorelick DA; Desrosiers NA; Huestis MA
Clin Chem; 2013 Dec; 59(12):1780-9. PubMed ID: 24046200
[TBL] [Abstract][Full Text] [Related]
19. Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.
Schwope DM; Karschner EL; Gorelick DA; Huestis MA
Clin Chem; 2011 Oct; 57(10):1406-14. PubMed ID: 21836075
[TBL] [Abstract][Full Text] [Related]
20. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]